✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals

Eiko Lifesciences Ltd.

EIKO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹69 Cr.
P/E
25.86

Eiko Lifesciences Ltd.

  • Eiko Lifesciences
  • Daikaffil Chemicals
  • Sunil Healthcare

FAQs on Eiko Lifesciences Ltd. Shareprice

Eiko Lifesciences has given lower returns compared to its competitors.
Eiko Lifesciences has grown at ~-7.82% over the last 2yrs while peers have grown at a median rate of -6.99%

Eiko Lifesciences is not expensive.
Latest PE of Eiko Lifesciences is 25.86, while 3 year average PE is 78.13.
Also latest EV/EBITDA of Eiko Lifesciences is 15.46 while 3yr average is 48.83.

View FAQ's On Business

Growth Table

  • Eiko Lifesciences Ltd.
  • Daikaffil Chemicals
  • Sunil Healthcare

Balance Sheet

  • Eiko Lifesciences Ltd.
  • Daikaffil Chemicals
  • Sunil Healthcare

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Eiko Lifesciences Ltd.
  • Daikaffil Chemicals
  • Sunil Healthcare

Cash Flow

  • Eiko Lifesciences Ltd.
  • Daikaffil Chemicals
  • Sunil Healthcare

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Eiko Lifesciences Ltd.
  • Daikaffil Chemicals
  • Sunil Healthcare

Quarterly Results

  • Eiko Lifesciences Ltd.
  • Daikaffil Chemicals
  • Sunil Healthcare

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Eiko Lifesciences Ltd. Financials

Balance sheet of Eiko Lifesciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Eiko Lifesciences is increasing.
Latest net debt of Eiko Lifesciences is -₹20.8 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹26.68 Crs.

Yes, profit is increasing.
The profit of Eiko Lifesciences is ₹2.94 Crs for TTM, ₹2.11 Crs for Mar 2025 and ₹0.75 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Eiko Lifesciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech